abagovomab 18
abciximab 19
abituzumab 17
abrilumab 10
actoxumab 7
adalimumab 12
aducanumab 7
afasevikumab 8
alacizumab_pegol 7
alemtuzumab 20
alirocumab 9
amatuximab 23
andecaliximab 15
anifrolumab 13
anrukinzumab 14
aprutumab 9
aprutumab_ixadotin 9
arcitumomab 12
ascrinvacumab 4
atezolizumab 13
atinumab 10
avelumab 8
basiliximab 13
bavituximab 15
begelomab 12
benralizumab 15
bevacizumab_beta 10
bezlotoxumab 7
bimagrumab 9
bleselumab 7
blinatumomab 18
blosozumab 24
bococizumab 11
brazikumab 9
brentuximab_vedotin 12
briakinumab 14
brodalumab 4
brolucizumab 21
brontictuzumab 10
burosumab 12
cabiralizumab 13
camrelizumab 8
canakinumab 19
cantuzumab_ravtansin 26
carlumab 11
carotuximab 9
cergutuzumab_amunaleukin2 21
cergutuzumab_amunaleukin 21
certolizumab_pegol 15
cetiximab 23
citatuzumab_bogatox 22
cixutumumab 13
clivatuzumab_tetraxetan 5
codrituzumab 18
conatumumab 6
concizumab 15
crenezumab 12
crizanlizumab 13
crotedumab 13
dacetuzumab 17
daclizumab 10
dalotuzumab 20
dapirolizumab_pegol 18
daratumumab 11
dectrekumab 8
demcizumab 16
denosumab 8
depatuxizumab 14
depatuxizumab_mafodotin 14
dezamizumab 10
dinutuximab 25
diridavumab 6
domagrozumab 12
drozitumab 5
duligotuzumab 11
durvalumab 4
dusigitumab 0
efalizumab 20
efungumab 15
eldelumab 6
elezanumab 6
elgemtumab 6
elotuzumab 8
emactuzumab 12
emapalumab 17
emibetuzumab 10
enavatuzumab 22
enfortumab_vedotin 5
enoblituzumab 13
enokizumab 15
enoticumab 11
ensituximab 16
eptinezumab 11
erenumab 5
etaracizumab 13
etrolizumab 16
evinacumab 15
evolocumab 3
farletuzumab 3
fasinumab 15
fezakinumab 6
fibatuzumab 3
ficlatuzumab 11
firivumab 19
flanvotumab 8
fletikumab 12
foralumab 6
foravirumab 11
fremanezumab 20
fresolimumab 16
fulranumab 17
futuximab 7
galcanezumab 6
ganitumab 18
gantenerumab 4
gemetuzumab 19
gemtuzumab2 16
gemtuzumab 15
gevokizumab 19
girentuximab 14
glembatumumab 9
glembatumumab_vedotin 9
guselkumab 16
ibalizumab 17
ibritumomab 9
icrucumab 5
idarucizumab 15
ifabotuzumab 3
imalumab 13
imgatuzumab 13
inclacumab 9
indatuximab_ravtansin 14
indusatumab 7
inebilizumab 18
intetumumab 5
iodine_girentuximab 25
ipilimumab 0
iratumumab 4
isatuximab 13
itolizumab 16
ixekizumab 19
labetuzumab_govitecan 14
lambrolizumab 18
lampalizumab 13
lanadelumab 13
landogrozumab 9
laprituximab 19
lebrikizumab 22
lendalizumab 19
lenzilumab 9
lifastuzumab_vedotin 19
ligelizumab 18
lilotomab 19
lirilumab 7
lodelcizumab 8
lokivetmab 14
lorvotuzumab_mertansin 7
lucatumumab 24
lumretuzumab 6
lupartumab 7
lutikizumab 13
margetuximab 23
milatuzumab 18
mirvetuximab 19
mirvetuximab_soravtansin 19
modotuximab 21
mogamulizumab 19
monalizumab 15
motavizumab 18
moxetumomab_pasudotox 16
namilumab 8
naratuximab 16
naratuximab_emtansin 16
narnatumab 11
navicixizumab2 19
navicixizumab 18
navivumab 17
necitumumab 6
nemolizumab 16
nesvacumab 10
nivolumab 7
obiltoxaximab 8
obinutuzumab 27
ocaratuzumab 15
ofatumumab 7
olaratumab 4
olokizumab 19
omalizumab 15
onartuzumab 16
ontuxizumab 7
opicinumab 11
orticumab 4
otelixizumab 26
oxelumab 6
ozanezumab 18
pamrevlumab 4
panobacumab 9
parsatuzumab 19
pasotuxizumab 17
pateclizumab 9
patritumab 10
pembrolizumab 18
perakizumab 12
pidilizumab 12
pinatuzumab_vedotin 10
plozalizumab 20
pogalizumab 16
polatuzumab_vedotin 12
ponezumab 22
prezalumab 10
pritoxaximab 16
quilizumab 14
racotumomab 15
radretumab 12
ralpancizumab 16
ramucirumab 10
ranevetmab 15
ranibizumab 7
refanezumab 15
remtolumab 12
rilotumumab 7
rinucumab 10
risankizumab 29
rituximab 12
rivabazumab 11
robatumumab 19
roledumab 16
romosozumab 16
rontalizumab 15
rosmantuzumab 17
rozanolixizumab 13
sacituzumab 12
sacituzumab_govitecan 12
samalizumab 14
sapelizumab 16
sarilumab 10
secukinumab 8
seribantumab 11
setoxaximab 23
sifalimumab 3
siltuximab 13
simtuzumab 18
sirukumab 7
solanezumab 19
solitomab 10
stamulumab 10
suptavumab 14
suvizumab 4
tabalumab 5
tadocizumab 4
tamtuvetmab 22
tanezumab 16
tarextumab 7
tavolixizumab 10
telisotuzumab 18
teplizumab 11
tesidolumab 11
tezepelumab 16
tigatuzumab 13
tildrakizumab 14
timolumab 6
tisotumab 4
tosatoxumab 17
tositumomab 9
tralokinumab 18
trastuzumab 18
tregalizumab 18
trevogrumab 8
ublituximab 12
urelumab 10
ustekinumab 16
utomilumab 16
vadastuximab 17
vadastuximab_talirin 17
vandortuzumab_vedotin 9
vantictumab 10
vanucizumab2 10
vanucizumab 15
varlilumab 11
vatelizumab 15
vedolizumab 11
veltuzumab 3
vesencumab 7
vorsetuzumab 15
vorsetuzumab_mafodotin 15
vunakizumab 20
xentuzumab 13
zatuximab 21
